Subtype
Cervical Neoplasm
CI-CAN-00004801Explore in graph →
Non-malignant573 active trials4 approved drugs14 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00004801Explore in graph →
Clinical trials
2,386 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07181720 | CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors | suspended | Phase 1 | 90 | Chongqing Precision Biotech Co., LtdINDUSTRY | 1 | Sep 11, 2026 | clinicaltrials |
| NCT03987555 | Paclitaxel Therapeutic Drug Monitoring in Cancer Patients | suspended | — | 55 | Wake Forest University Health SciencesOTHER | 1 | Aug 13, 2026 | clinicaltrials |
| NCT05337735 | A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers | suspended | Phase 2 | 140 | M.D. Anderson Cancer CenterOTHER | 1 | May 4, 2026 | clinicaltrials |
| NCT05506800 | Guangzhou Women's Health Cohort Study (GWHCS) | suspended | — | 1,000,000 | Guangzhou Women and Children's Medical CenterOTHER | 1 | Feb 23, 2023 | clinicaltrials |
| NCT00921635 | A Study to Evaluate the Impact of Maintaining Hemoglobin Levels in Anemic Patients With Carcinoma of the Cervix(HOSTT) | suspended | Phase 3 | 2 | Tri-Service General Hospital (TSGH)OTHER | 0 | Jun 19, 2009 | clinicaltrials |
Data updated 18 days agoSource updated Sep 11, 2026source: clinicaltrials